Avalon GloboCare(us:ALBT)

    3.42

    -12.08%

    Updated on 2024-12-22

    Open:3.63
    Close:3.42
    High:4.10
    Low:3.36
    Pre Close:3.89
    Volume:52831.00
    Amount:186218.91
    Turnover:4.74%
    Shares:1.11M
    MarketCap:3.81M
    DateTotalTotal SharesTotal RatioNewIncreasedDecreased
    2024-06-30142543852.21%432
    2024-03-3114997370.90%136
    2023-12-31161567071.42%435
    2023-09-30141354221.24%326
    2023-06-30151285811.23%224
    2023-03-31191590871.57%458
    2022-12-3120829620.08%437
    2022-09-305442620.04%231
    dateorgNametotalratiochangeShareschangeRatio
    2024-03-31Vanguard Group Inc345040.31%-33944-49.59%
    2024-03-31Geode Capital Management, Llc204240.18%0
    2024-03-31State Street Corp191200.17%0
    2024-03-31Millennium Management Llc127560.11%1200.95%
    2024-03-31Tower Research Capital Llc (Trc)81870.07%330.41%
    2024-03-31Ubs Group Ag45040.04%4504
    2024-03-31Morgan Stanley2000.00%-8-3.85%
    2024-03-31Wells Fargo & Company/Mn280.00%13.70%
    2024-03-31Sound Income Strategies, Llc100.00%0
    2024-03-31Royal Bank Of Canada40

    About

    Avalon GloboCare Corp. is a clinical-stage biotechnology company, which engages in the development of immune effector cell therapy and laboratory services. It operates through the Real Property Operating and Medical Related Consulting Services segments. The Real Property Operating segment includes property management fees, property insurance, real estate taxes, depreciation, repairs and maintenance fees, utilities and other expenses related to rental properties. The Medical Related Consulting segment relates to labor and related benefits, travel expenses, and related to consulting services. The company was founded on July 28, 2014 and is headquartered in Freehold, NJ.
    Address:4400 Route 9 South,Suite 3100

    Market Movers